Voltar
Revisão Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

2016; American Academy of Pediatrics; Volume: 138; Issue: 2 Linguagem: Inglês

10.1542/peds.2015-4387

ISSN

1098-4275

Autores

Edson Duarte Moreira, Stan L. Block, Daron Ferris, Anna R. Giuliano, Ole-Erik Iversen, Elmar A. Joura, Pope Kosalaraksa, Andrea Schilling, Pierre Van Damme, Jacob Bornstein, F. Xavier Bosch, Sophie Pils, Jack Cuzick, Suzanne M. Garland, Warner K. Huh, Susanne K. Kjær, Hong Qi, Donna Hyatt, Jason Martin, Erin Moeller, Michael Ritter, Martine Baudin, Alain Luxembourg,

Tópico(s)

Molecular Biology Techniques and Applications

Resumo

The overall safety profile of the 9-valent human papillomavirus (9vHPV) vaccine was evaluated across 7 Phase III studies, conducted in males and females (nonpregnant at entry), 9 to 26 years of age.

Referência(s)